CIK: 0001833486 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value ($000): $160,539 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TNYA | Tenaya Therapeutics, Inc. | 9,400,290 | $49,164 | 30.6% | $21.49 | -77.7% | COM | 87990A106 |
| ORIC | ORIC Pharmaceuticals Inc. | 3,540,777 | $48,686 | 30.3% | $28.69 | -58.6% | COM | 68622P109 |
| — | NGM Biopharmaceuticals Inc | 18,136,735 | $28,837 | 18.0% | $27.77 | — | COM | 62921N105 |
| — | RAPT Therapeutics Inc | 2,680,621 | $24,072 | 15.0% | $19.03 | — | COM | 75382E109 |
| — | Surrozen, Inc. | 616,540 | $9,686 | 6.0% | $6.84 | — | COM | 86889P109 |
| SGMT | Sagimet Biosciences Inc. | 17,169 | $93 | 0.1% | $7.18 | 0.0% | COM | 786700104 |
| RVMD | Revolution Medicines Inc | 46 | $1 | 0.0% | $34.24 | -13.4% | COM | 76155X100 |